Largest Pharmaceutical and Device Company Payments in New Jersey

The CMS Open Payments program requires pharmaceutical and medical device companies to disclose payments made to physicians and teaching hospitals. This analysis ranks the top companies by total payments made to providers in New Jersey. The top 25 companies collectively paid $153,886,329 to healthcare providers in this state.

Data source: CMS Open Payments + Medicare Part B Coverage: 2018–2024 Providers analyzed: 124,538 State: New Jersey
$153,886,329
Total Industry Payments
Across all providers in this analysis
124,538
Providers Analyzed
With at least one payment on record
Zimmer Biomet Holdings, Inc.
Top Paying Company
$34,452,301 total
Context: Industry payments to physicians are legally required to be disclosed under the Physician Payments Sunshine Act. Receiving payments does not imply wrongdoing. Payments may reflect consulting expertise, research participation, or speaking engagements. This data is provided to support transparency, not to render clinical judgments.

Top Companies by Total Payments to New Jersey Providers

CMS Open Payments
# Company Total Payments Doctors Paid Total Transactions
1 Zimmer Biomet Holdings, Inc. $34,452,301
2,561 14,284
2 Stryker Corporation $9,499,060
2,749 28,507
3 AstraZeneca Pharmaceuticals LP $9,177,549
9,230 123,584
4 ABBVIE INC. $8,767,778
10,147 128,834
5 Intuitive Surgical, Inc. $5,707,918
682 11,631
6 Amgen Inc. $5,377,788
7,799 90,477
7 Abbott Laboratories $5,321,431
5,238 52,377
8 Novo Nordisk Inc $5,197,814
6,193 123,834
9 PFIZER INC. $5,063,323
10,515 92,152
10 Lilly USA, LLC $5,054,096
6,609 77,685
11 GlaxoSmithKline, LLC. $4,917,531
7,486 91,802
12 DePuy Synthes Products, Inc. $4,550,419
24 291
13 Align Technology, Inc. $4,443,393
2,017 10,985
14 Allergan, Inc. $4,429,069
3,379 22,817
15 Medtronic, Inc. $4,371,447
4,923 29,797
16 Takeda Pharmaceuticals U.S.A., Inc. $4,049,615
4,335 33,463
17 Janssen Pharmaceuticals, Inc $3,983,166
7,179 68,638
18 Medtronic Vascular, Inc. $3,979,571
1,259 9,999
19 Boehringer Ingelheim Pharmaceuticals, Inc. $3,944,109
5,740 56,543
20 E.R. Squibb & Sons, L.L.C. $3,905,206
4,841 42,994
21 Gilead Sciences, Inc. $3,658,965
2,865 24,044
22 Merck Sharp & Dohme Corporation $3,617,664
6,853 39,756
23 GENZYME CORPORATION $3,573,294
3,193 23,802
24 AbbVie Inc. $3,507,743
6,584 60,617
25 Smith+Nephew, Inc. $3,336,079
2,137 11,810

State payment context — New Jersey

CMS Open Payments

Across 46,038 New Jersey providers with at least one disclosed industry payment over 2018–2024, the median provider received $371 in total payments, compared with a national median of $339 across 1,571,086 paid providers.

New Jersey accounts for 2.1% of the $16,205,257,917 in industry payments recorded nationwide in this database, and its per-provider median runs above the national benchmark.

Top specialties by median industry payment — New Jersey

Specialty Median per provider Providers paid Total payments
Clinical Cardiac Electrophysiology Physician $25,072 44 $2,829,660
Adult Reconstructive Orthopaedic Surgery Physician $12,319 36 $7,412,071
Orthopaedic Surgery of the Spine Physician $8,109 73 $3,464,883
Hematology $7,889 40 $8,397,270
Interventional Cardiology $6,928 105 $2,385,232

Industry payments in New Jersey by year

Year Total payments Providers paid Transactions
2018 $45,986,262 20,759 380,627
2019 $48,810,387 21,147 393,830
2020 $34,524,888 17,106 229,998
2021 $43,875,590 23,514 376,248
2022 $49,751,493 26,230 430,479
2023 $62,150,201 28,391 469,426
2024 $57,511,794 29,879 512,157
Methodology Company payment totals aggregated from CMS Open Payments records for providers licensed in New Jersey. Includes all payment categories (research, consulting, speaking, meals, travel, and other). Rankings reflect cumulative payments across all available years, not annualized figures. Data source: CMS Open Payments, accessed via doctransparency.com database.
Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →